Study Objective. To compare treatment adequacy in the management of depression during
the acute and continuation phases between patients newly treated with venlafaxine …

The traditional analysis of clinical trial data for antidepressants separately evaluates the
results of efficacy and tolerability. The present analysis simultaneously evaluated these …

This double-blind, placebo-controlled study compared venlafaxine (immediate release), the
first modern serotonin-norepinephrine reuptake inhibitor, with the selective serotonin …

High doses of antidepressants are often used for treatment-resistant depression.
Venlafaxine, a dual serotonin and noradrenaline reuptake inhibitor, has been shown to have …

Venlafaxine, a dual serotonin and noradrenaline re-uptake inhibitor, has been found to be
effective at doses below 375 mg daily, but for patients with major depression higher doses …

In this randomized, open-label, 8-week comparative study, the efficacy and safety of
venlafaxine and fluoxetine were assessed in outpatients with major depression. One …

Objective: The purpose of this retrospective analysis was to estimate the cost and
effectiveness of venlafaxine extended-release (VXR) compared with selective serotonin …

Background: Quantifying efficacy and safety differences between drugs is difficult because
rigorous statistical methods to assess benefit and risk simultaneously are lacking. Methods …

OBJECTIVE: The rate of adverse events following discontinuation of treatment with extended-
release venlafaxine was compared with the rate associated with discontinuation of placebo …

Background: We compared the efficacy and tolerability of venlafaxine XR with that of
fluoxetine in a multicenter, randomized, double-blind, placebo-controlled study in depressed …